Immunotherapy with Keytruda (Pembolizumab) Doctors Abroad — Page 3

Professor Serdar Bedii Omay is a dual-qualified haematologist and oncologist who earned his PhD from Japan Mie Medical School. He specialises in treating resistant blood cancers at Emsey Hospital.

• Manages immunotherapy protocols for resistant Non-Hodgkin and Hodgkin lymphoma cases
• Expert in CAR T-cell therapy and molecular haematology research
• Published over 65 scientific articles in international medical journals
• Former Professor of Haematology at two leading Turkish universities
• Member of the bone marrow transplant unit featuring 45 high-intensity care beds

Associate Professor Ayse Irem Yasin is an ESMO-certified board oncologist who specialises in immunotherapy targets for solid tumours at Medipol Acibadem District Hospital.

• Holds a European Society for Medical Oncology (ESMO) Board Certificate from Paris
• Completed a specialised breast cancer unit residency at Maggiore della Carita Hospital in Italy
• Gained clinical experience at world-leading institutions including Harvard Medical School and Cleveland Clinic
• Expertise covers complex immunotherapy applications for lung, gastrointestinal, and gynaecological cancers

Associate Professor Nail Paksoy is a Board Certified medical oncologist who specialises in immunotherapy and advanced cancer clinical trials.

• ESMO Board Certified in Medical Oncology, recognised by the professional body for oncology in Europe
• Serves as a Sub-Investigator for multiple international clinical trials involving Pembrolizumab (Keytruda)
• Completed a specialised fellowship in Allergy and Immunology, providing deep insight into immune system responses
• Associate Professor at Medipol University, where he contributes to the next generation of cancer specialists

Professor Birol Baytan has performed 950 bone marrow transplants and leads one of Turkey's largest paediatric transplant units at Emsey Hospital.

• Specialises in managing complex solid tumours including neuroblastoma, brain tumours, and Ewing sarcoma
• Provides immunotherapy with Keytruda alongside advanced CAR T-cell therapy protocols
• Expert in identifying genetic changes in cancer cells through cytogenetic studies
• Published 15 articles in international medical journals on paediatric blood disorders
• Author of three medical books focused on childhood health and oncology

Associate Professor Abdullah Sakin is the former Head of Medical Oncology at Yüzüncü Yıl University Faculty of Medicine and currently leads medical oncology at Medipol Bahçelievler Hospital.

• Specialises in internal medicine and medical oncology with a focus on advanced cancer therapies
• Served as Education Officer at the Prof Dr Cemil Taşçıoğlu City Hospital medical oncology clinic
• Contributes to clinical research and the education of future oncology specialists
• Recognised for managing complex cases within Turkish university and training hospital systems

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.

Professor Sridhar P.S. is a senior radiation oncologist at HCG Manavata Cancer Centre who integrates immunotherapy with advanced precision treatments. He holds a Diplomate of the National Board in radiotherapy and focuses on complex oncology cases.

• Member of the Society for Neuro-Oncology involving brain tumour cases
• International experience in combining targeted drug therapy with radiotherapy
• Specialises in managing immunotherapy protocols for solid tumours
• Active member of the Association of Radiation Oncology of India

Dr. Girish Badarkhe is a hematology-oncologist at HCG Manavata Cancer Centre in Nashik. He specializes in leukemia, multiple myeloma, and bone marrow transplants. Dr. Badarkhe treats both adults and children with complex blood disorders. He holds a DM in Clinical Hematology from Medical College, Calcutta.

• Performs allogenic and haploidentical bone marrow transplant procedures.
• Treats blood cancers including lymphoma and acute lymphoblastic leukemia.
• Completed medical training at Grant Medical College and Sir JJ Hospital.
• Works at Maharashtra's first NABH-accredited cancer hospital.

Professor Shaunak Valame is a specialist medical oncologist at HCG Manavata Cancer Centre with expert knowledge in molecular cancer markers and targeted therapies.

• Presented stomach cancer research at the American Society of Clinical Oncology symposium in San Francisco
• Completed oncology training at the prestigious Indraprastha Apollo Hospital in New Delhi
• Lectured at the International Winter School of Oncology programme at AIIMS
• Focuses on the molecular basis of cancer to tailor immunotherapy protocols
• Handled registrar and senior residency roles at major regional cancer research centres